Study on the effects of intraoperative administration of dexmedetomidine on the prognosis and survival outcomes of patients with colorectal cancer
The intraoperative application of dexmedetomidine as an adjuvant analgesic has a protective effect on the prognosis and survival of patients with CRC and can improve the overall survival rate. Additionally, it influences the recurrence status of patients to a certain extent. These results suggest that dexmedetomidine significantly benefits on the long-term prognosis of patients with CRC.
Authors
- Dexing Luo (ORCID: https://orcid.org/0000-0001-7928-6168)
- Junfang Wang (ORCID: https://orcid.org/0000-0003-3670-5398)
- Chu Ren
- Liuji Qiu (ORCID: https://orcid.org/0000-0001-8236-6871)
- Ying Zeng (ORCID: https://orcid.org/0000-0002-5555-6036)
- Yan Yan (ORCID: https://orcid.org/0000-0003-2120-4662)
- Xin Chen (ORCID: https://orcid.org/0000-0002-5579-0447)
Institutions
- Jiaying University (CN)
- Guangdong Medical College (CN)
- Shantou University (CN)
- Shantou University Medical College (CN)
- Huizhou Central People's Hospital (CN)
Publication Details
- Journal
- Heliyon
- Published
- 2024-09-21
- DOI
- https://doi.org/10.1016/j.heliyon.2024.e38241
- Citations
- 4
- Primary Topic
- Cancer, Stress, Anesthesia, and Immune Response
- Type
- article
- Field-Weighted Citation Impact
- 1.54
Funders
- Medical Science and Technology Foundation of Guangdong Province
- Basic and Applied Basic Research Foundation of Guangdong Province